# The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD

> **NCT03081156** · PHASE4 · COMPLETED · sponsor: **William Stringer, md** · enrollment: 52 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Glycopyrrolate / Formoterol Inhaler vs Placebo Inhaler

## Key facts

- **NCT ID:** NCT03081156
- **Lead sponsor:** William Stringer, md
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-27
- **Primary completion:** 2019-01-01
- **Final completion:** 2019-01-31
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03081156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03081156, "The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03081156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*